FI883594A - Hedelmöitystä ehkäisevä implantti - Google Patents

Hedelmöitystä ehkäisevä implantti Download PDF

Info

Publication number
FI883594A
FI883594A FI883594A FI883594A FI883594A FI 883594 A FI883594 A FI 883594A FI 883594 A FI883594 A FI 883594A FI 883594 A FI883594 A FI 883594A FI 883594 A FI883594 A FI 883594A
Authority
FI
Finland
Prior art keywords
implant
infertility
locally
release
long time
Prior art date
Application number
FI883594A
Other languages
English (en)
Swedish (sv)
Other versions
FI883594A0 (fi
FI93421B (fi
FI93421C (fi
Inventor
Nijs Hendrik De
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19850428&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI883594(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI883594A0 publication Critical patent/FI883594A0/fi
Publication of FI883594A publication Critical patent/FI883594A/fi
Publication of FI93421B publication Critical patent/FI93421B/fi
Application granted granted Critical
Publication of FI93421C publication Critical patent/FI93421C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
FI883594A 1987-08-08 1988-08-01 Hedelmöitystä ehkäisevä implantti FI93421C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8701868 1987-08-08
NL8701868 1987-08-08

Publications (4)

Publication Number Publication Date
FI883594A0 FI883594A0 (fi) 1988-08-01
FI883594A true FI883594A (fi) 1989-02-09
FI93421B FI93421B (fi) 1994-12-30
FI93421C FI93421C (fi) 1995-04-10

Family

ID=19850428

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883594A FI93421C (fi) 1987-08-08 1988-08-01 Hedelmöitystä ehkäisevä implantti

Country Status (19)

Country Link
US (3) US4957119A (fi)
EP (1) EP0303306B1 (fi)
JP (1) JP2571831B2 (fi)
KR (1) KR950008763B1 (fi)
CN (1) CN1024753C (fi)
AT (1) ATE86484T1 (fi)
AU (1) AU603475B2 (fi)
CA (1) CA1309949C (fi)
DE (2) DE19975054I2 (fi)
DK (1) DK173166B1 (fi)
ES (1) ES2054784T3 (fi)
FI (1) FI93421C (fi)
HK (1) HK1002020A1 (fi)
IE (1) IE61730B1 (fi)
MX (1) MX9203817A (fi)
NL (1) NL980027I2 (fi)
NZ (1) NZ225399A (fi)
PT (1) PT88220B (fi)
ZA (1) ZA885034B (fi)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US5156164A (en) * 1988-10-13 1992-10-20 Leveen Harry H Iodine contraceptive sponge
BE1002600A3 (fr) * 1988-11-23 1991-04-09 Wildemeersch Dirk Dispositif intra-uterin perfectionne.
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
WO1993017662A1 (en) * 1992-03-02 1993-09-16 Daratech Pty. Ltd. Improved implants
DE69329407T2 (de) * 1992-06-02 2001-05-03 Bard Inc C R Verfahren und Implantatvorrichtung für Langzeitwirkstoffabgabe
US5368588A (en) * 1993-02-26 1994-11-29 Bettinger; David S. Parenteral fluid medication reservoir pump
US5443461A (en) * 1993-08-31 1995-08-22 Alza Corporation Segmented device for simultaneous delivery of multiple beneficial agents
US5681817A (en) 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
DE19539361A1 (de) * 1995-10-23 1997-04-24 Basf Ag Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
US5733565A (en) * 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant
CN1088993C (zh) * 1996-10-11 2002-08-14 上海市计划生育科学研究所 含孕二烯酮的长效皮下避孕埋植剂
US6203813B1 (en) 1997-01-13 2001-03-20 Lance L. Gooberman Pharmaceutical delivery device and method of preparation therefor
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
DE19744135C1 (de) * 1997-09-29 1999-03-25 Schering Ag Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
DE69929055T2 (de) 1998-05-01 2006-07-20 Duramed Pharmaceuticals Inc., Cincinnati Verfahren zur spritzgussherstellung von vorrichtungen mit kontrollierter wirkstofffreisetzung und damit hergestellte vorrichtung
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
EP1098653A2 (en) * 1998-07-17 2001-05-16 PHARMACIA & UPJOHN COMPANY Subcutaneous medroxyprogesterone acetate for contraception
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US6117442A (en) * 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
CA2267743C (en) 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
MXPA03001147A (es) * 2000-08-23 2003-10-06 Akzo Nobel Nv Nueva formulacion de ester de testosterona para uso humano.
AU2003267309A1 (en) 2000-11-16 2004-04-08 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
CN1289063C (zh) 2001-05-11 2006-12-13 奥索-麦克尼尔药品公司 用于动物的免疫调节装置
US8058441B2 (en) 2001-07-02 2011-11-15 N.V. Organon Tetrahydroquinoline derivatives
KR20040036928A (ko) * 2001-08-31 2004-05-03 쉐링 오와이 약물 전달 시스템
HUP0401443A3 (en) 2001-09-04 2008-05-28 Organon Nv Glycine-substituted thieno[2,3-d]pyrimidines with lh and fsh agonistic activity, use of the compounds and pharmaceutical compositions containing same
TWI228508B (en) 2001-09-04 2005-03-01 Akzo Nobel Nv Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
NZ534317A (en) * 2002-01-24 2006-06-30 Smart Drug Systems Inc Sustained release pharmaceutical composition carried in or on silicone support material
JP2005519964A (ja) * 2002-03-11 2005-07-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ スルファターゼ阻害プロゲストゲンのみの避妊レジメン
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
KR20100120243A (ko) * 2002-05-07 2010-11-12 피시비다 유에스 인코포레이티드 약물 전달 장치를 형성하는 공정
NZ536965A (en) * 2002-05-31 2007-02-23 Titan Pharmaceuticals Inc Nonerodible polymeric matrix with buprenorphine encapsulated for the treatment of opiate addiction and pain
ATE345804T1 (de) * 2002-08-28 2006-12-15 Robert Casper Estrogenersatztherapie
DE60332769D1 (de) 2002-11-07 2010-07-08 Organon Nv Indole, die sich zur behandlung von mit dem androgenrezeptor in zusammenhang stehenden krankheiten eignen
TWI322012B (en) 2002-12-20 2010-03-21 Organon Nv Tetrahydroquinoline derivatives
TWI306855B (en) 2002-12-20 2009-03-01 Organon Nv Tetrahydroquinoline derivatives
MXPA05010450A (es) * 2003-03-31 2005-11-04 Titan Pharmaceuticals Inc Dispositivo polimerico implantable para la liberacion prolongada de agonistas de dopamina.
US7833545B2 (en) * 2003-04-29 2010-11-16 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
TWI336627B (en) 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
US20050031668A1 (en) * 2003-05-30 2005-02-10 Patel Rajesh A. Implantable polymeric device for sustained release of nalmefene
US20070259014A1 (en) * 2003-06-20 2007-11-08 Vgx Pharmaceuticals, Inc. Compositions for and Methods for Treating Hiv
EP1703916A2 (en) * 2004-01-13 2006-09-27 Vasogenix Pharmaceuticals, Inc. Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
CA2552757A1 (en) * 2004-01-13 2005-08-04 Vasogenix Pharmaceuticals, Inc. Methods of using cgrp for cardiovascular and renal indications
EP1703895A2 (en) * 2004-01-13 2006-09-27 Vasogenix Pharmaceuticals, Inc. Controlled release cgrp delivery composition for cardiovascular and renal indications
TWI434676B (zh) * 2004-03-19 2014-04-21 Merck Sharp & Dohme 可用ｘ射線看出之藥物遞送裝置
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
TW200602317A (en) 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
ATE372772T1 (de) † 2004-07-13 2007-09-15 Schering Oy Retardiertes freigabesystem mit kontrollierter initialabgabe
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
CA2612387A1 (en) 2005-06-15 2006-12-28 Hydra Biosciences, Inc. Modulators of sperm hypermotility and uses thereof
EP1743638A1 (en) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Pharmaceutical formulations of substituted pyrazoline compounds
US7682356B2 (en) 2006-08-09 2010-03-23 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies for use therein
US7989442B2 (en) 2006-09-27 2011-08-02 N.V. Organon Progesterone receptor modulators
CN101209238B (zh) * 2006-12-27 2012-05-09 辽宁省计划生育科学研究院 含孕二烯酮的生物降解型长效皮下避孕埋植剂及其制备
CN105688191A (zh) 2007-04-23 2016-06-22 精达制药公司 促胰岛素释放肽的混悬制剂及其应用
US8063037B2 (en) 2007-05-07 2011-11-22 N. V. Organon Progesterone receptor modulators
CN101130057B (zh) * 2007-07-06 2011-04-27 复旦大学 胸腺五肽长效植入剂及其制备方法
TW200930343A (en) 2007-09-21 2009-07-16 Organon Nv Drug delivery system
WO2009069130A2 (en) 2007-11-27 2009-06-04 Ramot At Tel-Aviv University Ltd. New adjuvant
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
US8298561B2 (en) 2009-09-28 2012-10-30 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
WO2011079232A1 (en) * 2009-12-23 2011-06-30 Psivida Us, Inc. Sustained release delivery devices
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
AR089765A1 (es) * 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
AU2014214537B2 (en) 2013-02-06 2019-01-03 Mark SILLENDER Therapeutic substance transfer catheter and method
WO2014121333A1 (en) 2013-02-06 2014-08-14 Sillender Mark Embryo transfer catheter and method
EP3079659B1 (en) 2013-12-11 2020-10-28 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
WO2016149561A1 (en) * 2015-03-17 2016-09-22 Oak Crest Institute Of Science Subdermal implants for the sustained delivery of water-soluble drugs
CA2987766A1 (en) 2015-06-03 2016-12-08 Intarcia Therapeutics, Inc. Implant placement and removal systems
MX2018014016A (es) 2016-05-16 2019-08-01 Intarcia Therapeutics Inc Polipéptidos selectivos del receptor de glucagón y métodos para utilizarlos.
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
US9980850B2 (en) 2016-09-29 2018-05-29 Gesea Biosciences, Inc. Bioerodible contraceptive implant and methods of use thereof
WO2018129058A1 (en) 2017-01-03 2018-07-12 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
US11571328B2 (en) 2018-04-09 2023-02-07 Medicines360 IUD insertion devices
US11690806B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
MX2020012458A (es) * 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
US20200261258A1 (en) 2019-02-19 2020-08-20 Medicines360 Devices, systems, methods and kits for insertion and removal of iuds
BR102020007749A2 (pt) 2020-04-17 2021-11-03 Edson Luiz Peracchi Implante subcutâneo reabsorvível de longa duração com liberação controlada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da endometriose
BR102020010923A2 (pt) 2020-05-29 2021-12-14 Luiz Peracchi Edson Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da insuficiência adrenal crônica ou hipocortisolismo
BR102020013862A2 (pt) 2020-07-07 2022-01-18 Edson Luiz Peracchi Implante subcutâneo reabsorvível de longa duração com liberação sustentada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da doença de parkinson
WO2022204771A1 (pt) 2021-03-29 2022-10-06 Edson Luiz Peracchi Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento do hipotireoidismo e processo
CN113209050A (zh) * 2021-05-14 2021-08-06 浙江恒冀制药有限责任公司 基于生物相容性聚合物的长效体内皮埋或内植缓释制剂
WO2024184356A1 (en) * 2023-03-06 2024-09-12 Institut National de la Santé et de la Recherche Médicale Miniaturized implants for the inner ear
GB202401392D0 (en) 2024-02-02 2024-03-20 Imphatec Ltd Implant for delivery of a drug

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903880A (en) * 1972-08-17 1975-09-09 Alza Corp Intrauterine device for managing the reproductive process
US3926188A (en) * 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
US4582052A (en) * 1982-03-23 1986-04-15 Repromed, Inc. Povidone-iodine dispensing fiber
NZ200564A (en) * 1982-05-10 1987-03-06 Ahi Operations Ltd Device for slowly releasing chemicals into body cavities of animals
US4601714A (en) * 1983-07-07 1986-07-22 Burnhill Michael S Vaginal device
US4629621A (en) * 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
EP0180264A1 (en) * 1984-10-12 1986-05-07 Akzo N.V. Release system for two or more active substances
US4720384A (en) * 1985-05-03 1988-01-19 E. I. Du Pont De Nemours And Company Manufacture of hollow fine tubular drug delivery systems
US4673565A (en) * 1985-05-03 1987-06-16 E. I. Du Pont De Nemours And Company Pharmaceutical compositions containing hollow fine tubular drug delivery systems

Also Published As

Publication number Publication date
DE19975054I2 (de) 2000-04-13
EP0303306B1 (en) 1993-03-10
DE3879031T2 (de) 1993-06-24
JPS6470410A (en) 1989-03-15
EP0303306A1 (en) 1989-02-15
US5088505A (en) 1992-02-18
NL980027I2 (nl) 1999-02-01
CN1024753C (zh) 1994-06-01
HK1002020A1 (en) 1998-07-24
US4957119A (en) 1990-09-18
IE61730B1 (en) 1994-11-30
ES2054784T3 (es) 1994-08-16
NL980027I1 (nl) 1998-12-01
FI883594A0 (fi) 1988-08-01
KR950008763B1 (en) 1995-08-08
CN1031323A (zh) 1989-03-01
DE3879031D1 (de) 1993-04-15
FI93421B (fi) 1994-12-30
CA1309949C (en) 1992-11-10
ATE86484T1 (de) 1993-03-15
AU2044988A (en) 1989-03-02
MX9203817A (es) 1992-08-01
DK438688D0 (da) 1988-08-05
PT88220B (pt) 1995-03-01
US5150718A (en) 1992-09-29
IE882118L (en) 1989-02-08
ZA885034B (en) 1989-03-29
PT88220A (pt) 1989-06-30
FI93421C (fi) 1995-04-10
DK438688A (da) 1989-02-09
NZ225399A (en) 1990-09-26
KR890003360A (ko) 1989-04-14
AU603475B2 (en) 1990-11-15
JP2571831B2 (ja) 1997-01-16
DK173166B1 (da) 2000-02-28

Similar Documents

Publication Publication Date Title
FI883594A (fi) Hedelmöitystä ehkäisevä implantti
DE3877174D1 (de) Bezugssystem zur implantation von kondylaeren knie-totalprothesen.
DE3864941D1 (de) Mechanische penisprothese.
GB8901974D0 (en) Plastic retainer for bearing
DE3862538D1 (de) Trennungsmittel.
DE3887839D1 (de) Trennmittelzusammensetzung.
NL194747B (nl) Preparaat voor de afgifte van diltiazem.
FI875658A (fi) Terraengskida med en fraon dess ovansida uppstaoende laengsgaoende list.
NO882476L (no) Fremgangsmaate for installasjon av en broennramme paa havbunnen.
NO885045D0 (no) Fremstillingssystem for pŸtrykte kondomer.
NL193761B (nl) Mechanisch-elektrische verhinderinrichting voor schakelaars.
NO883443L (no) Loesbar mekanisk kobling for strekkopptagende forankring.
DE3868432D1 (de) Automatisches steuerungsverfahren fuer den schussfadeneintrag.
DE69021536D1 (de) Zahnimplantatsystem.
ES510927A0 (es) "un procedimiento para la preparacion de esteres de mercapto acil-carnitina".
GR3005836T3 (fi)
EP0287763A3 (en) Device to keep open a uretrotomic incision
GR3004054T3 (fi)
EP0280152A3 (en) Water-proofing agent for leather
BR8701354A (pt) Sistema mecanico para implantacao de tuneis
ES1005821Y (es) Colgante de identificacion
ATE85883T1 (de) Stomaverschluss.
SE8704136L (en) Nest for pelt animal breeding - has base and at least part of its walls of light concrete
IT8143517A0 (it) Protesi per operati di colostomia
ES1015788Y (es) Calzado de seguridad perfeccionado.

Legal Events

Date Code Title Description
BB Publication of examined application
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L157

Extension date: 20130731

FG Patent granted

Owner name: AKZO NOBEL N.V.

PC Transfer of assignment of patent

Owner name: N.V. ORGANON

Free format text: N.V. ORGANON

MA Patent expired